Cabozantinib (brand name Cabometyx) is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and advanced differentiated thyroid cancer. It acts by blocking cancer cell multiplication and angiogenesis. Common side effects include diarrhea, fatigue, hypertension, and nausea
See It Styled On Instagram
- No access token
Reviews
There are no reviews yet.